OTHER × Observational × Carcinoma, Ovarian Epithelial × Clear all Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Completed
51 enrolled 28 charts
GREAT
Completed
1,500 enrolled
IMPrOVE
Recruiting
300 enrolled
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
Completed
10 enrolled
IOSI-GYNE-001
Recruiting
74 enrolled
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Recruiting
250 enrolled
ORACLE
Recruiting
168 enrolled
REMISSION
Recruiting
1,500 enrolled
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Recruiting
6,000 enrolled
INFLUENCE
Active not recruiting
70 enrolled
CUKUROVA
Recruiting
130 enrolled
Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients
Completed
1,108 enrolled
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
Completed
1,352 enrolled
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Not yet recruiting
100 enrolled
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Unknown
45 enrolled
SUROVA
Unknown
5,000 enrolled
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Unknown
1,000 enrolled
A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Not yet recruiting
60 enrolled
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Unknown
20 enrolled
OutCoME
Unknown
75 enrolled
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
5,000 enrolled
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
1,400 enrolled
Ovarian Tumor Biopsies to Study Response to Treatments
Completed
5 enrolled
Chromosomal Instability in Ovarian Cancer
Unknown
300 enrolled
HRD and Resistance to PAPPi in EOC Patients
Unknown
400 enrolled
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
Completed
240 enrolled
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Completed
316 enrolled
PaVaClO
Completed
550 enrolled
A Training Set for the HRD Model in EOC
Unknown
200 enrolled
Genetic Mutation in Epithelial Ovarian Cancer
Unknown
500 enrolled
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
Unknown
1,300 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
Completed
581 enrolled
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors
Unknown
40 enrolled
A Multi-omics Study of Epithelial Ovarian Cancer
Unknown
80 enrolled
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Unknown
1,000 enrolled
Ovaire01
Unknown
376 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Completed
525 enrolled
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Unknown
750 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
Terminated
9 enrolled
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
Completed
44 enrolled
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Completed
109 enrolled
ENCOURAGE
Completed
500 enrolled
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Completed
20 enrolled
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
Completed
17 enrolled
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
Terminated
11 enrolled
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Completed
605 enrolled